Which endpoint: mean intraocular pressure or proportion of successful patients?
A reduction in intraocular pressure in clinical trials can be determined through the mean intraocular pressure, through the proportion of patients who have the intraocular pressure reduced to a specific target intraocular pressure, or both. Since both these possible endpoints measure the shift of 2 intraocular pressure distributions, we recommend that only one of them be tested. In general, testing the difference between mean-values is much more efficient than testing the difference between proportions. However, proportions of successful patients are valuable in showing the clinical implication of a reduction in mean intraocular pressure, particularly when evaluating a moderate pressure reduction. The effect of a small mean intraocular pressure reduction on the probability to reach the target intraocular pressure is pointed out, particularly the fact that it can be substantial even if the mean reduction is smaller than the measurement error.
Hedman
Katarina
K
Department of Neuroscience-Ophthalmology, Uppsala University Hospital, Uppsala, Sweden. katarina.hedman@pharmacia.com
Taube
Adam
A
D003627:Data Interpretation, Statistical; D004334:Drug Administration Schedule; D005902:Glaucoma, Open-Angle / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D000077338:Latanoprost; D008962:Models, Theoretical; D009798:Ocular Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D009994:Osmolar Concentration; D017063:Outcome Assessment, Health Care; D011461:Prostaglandins F, Synthetic / Q000008:administration & dosage*; D012107:Research Design; D013997:Time Factors; D016896:Treatment Outcome
D011461:Prostaglandins F, Synthetic; D000077338:Latanoprost